Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Mitsuo Sakato"'
Autor:
Naoto Tadano, Sachio Morimoto, Akira Yoshimura, Makoto Miura, Kimitomo Yoshioka, Mitsuo Sakato, Iwao Ohtsuki, Yoshikazu Miwa, Fumi Takahashi-Yanaga, Toshiyuki Sasaguri
Publikováno v:
Journal of Pharmacological Sciences, Vol 97, Iss 1, Pp 53-60 (2005)
We investigated the effects of the agent SCH00013 on Ca2+-induced force generation in rabbit skinned cardiac muscle fibers and in vivo cardiac function in high-pacing-induced heart failure dogs. The Ca2+-induced force generation in skinned cardiac mu
Externí odkaz:
https://doaj.org/article/ef03b378013c4bc18d1eabe6fd8d5ecf
Autor:
Mitsuo Sakato, Akira Yoshimura, Masataka Hino, Masao Endoh, Hiromi Sugawara, Kimitomo Yoshioka
Publikováno v:
Arzneimittelforschung. 49:412-419
Influence of 4,5-dihydro-6-[1-[2-hydroxy-2-(4-cyanophenyl)ethyl]- 1,2,5,6,-tetrahydropyrido-4-yl]pyridazin-3(2H)-one (SCH00013) and vesnarinone (CAS 81840-15-5) on the arrhythmia experimentally induced by three different methods was investigated in d
Autor:
Kimitomo Yoshioka, Masataka Hino, Akira Yoshimura, Akihiko Ogura, Hiromi Sugawara, Masao Endoh, Mitsuo Sakato
Publikováno v:
Arzneimittelforschung. 49:407-411
In order to clarify the mechanism of action of 4,5-dihydro-6-[1-[2-hydroxy-2-(4-cyanophenyl)ethyl]-1,2,5,6- tetrahydropyrido-4-yl]pyridazin-3(2H)-one (SCH00013), a novel cardiotonic agent with Ca++ sensitizing action, its effects on contractile force
Publikováno v:
Journal of Toxicologic Pathology. 9:305-313
Protective effect of Sobuzoxane (MST-16) against cardiotoxicity of adriamycin (ADM) was inves-tigated in rabbits. ADM (1.0mg/kg) was administered intravenously twice a week for five weeks. MST-16(25mg/kg, p.o.) or ICRF- 187 (25mg/kg, i.p.) was admini
Autor:
Masataka Hino, Akihiko Ogura, Masao Endoh, Hiromi Sugawara, Kimitomo Yoshioka, Mitsuo Sakato, Akira Yoshimura
Publikováno v:
ChemInform. 30
Autor:
Shinichi Yaguchi, Katsuyasu Sakita, Yasuhiro Izumisawa, Masanobu Kato, Ichiro Koshimizu, Kimitomo Yoshioka, Tsutomu Nakagane, Seiichiro Kawashima, Makoto Sato, Mitsuo Sakato
Publikováno v:
Biological and Pharmaceutical Bulletin. 20:698-700
We examined in vitro cytotoxic activity of imidazolyl-1, 3, 5-triazine derivatives using human breast cancer cell lines (MCF-7, R-27, T-47D and ZR-75-1) and murine leukemia cell line (P388). The percentage of viable cells was determined by the 3-(4,
Autor:
Fumi Takahashi-Yanaga, Iwao Ohtsuki, Kimitomo Yoshioka, Naoto Tadano, Akira Yoshimura, Yoshikazu Miwa, Makoto Miura, Toshiyuki Sasaguri, Sachio Morimoto, Mitsuo Sakato
Publikováno v:
Journal of Pharmacological Sciences, Vol 97, Iss 1, Pp 53-60 (2005)
We investigated the effects of the agent SCH00013 on Ca2+-induced force generation in rabbit skinned cardiac muscle fibers and in vivo cardiac function in high-pacing-induced heart failure dogs. The Ca2+-induced force generation in skinned cardiac mu
Publikováno v:
Journal of cardiovascular pharmacology. 42(3)
The authors examined the effects of long-term treatment with SCH00013, a novel cardiotonic agent with calcium-sensitizing action, on survival of hereditary cardiomyopathic BIO 14.6 hamsters. Sixty-nine male hamsters at 223 days of age were divided in
Autor:
Masanobu Kato, Tetsuo Watanabe, Hiroya Sasahara, Seiichiro Kawashima, Masahiro Inaba, Shinichi Yaguchi, Toshiyuki Matsuno, Mitsuo Sakato, Kimitomo Yoshioka, Masayuki Takahashi
Publikováno v:
ChemInform. 32
Triamino-substituted 1,3,5-triazine and pyrimidine derivatives were synthesized and tested for antitumor activities using some human cancer cell lines and murine leukemia cell lines. All the compounds having benzimidazolyl and morpholino groups as su
Autor:
Akira Yoshimura, Hiromi Sugawara, Masao Endoh, Kimitomo Yoshioka, Masataka Hino, Mitsuo Sakato
Publikováno v:
Japanese Journal of Pharmacology. 79:180